23 October 2015 - Merck & Co. is dropping the price of its blockbuster arthritis medicine Remicade by 25 percent in the U.K. through discounts and rebates to retain market share after cheaper copies became available in February.

For more details, go to: http://www.bloomberg.com/news/articles/2015-10-22/merck-co-discounts-remicade-by-25-in-u-k-to-fend-off-rivals